Clik here to view.
居家医疗保健 – 京都大学创新中心和松下开发的雷达健康监护仪获得重大升级
日本京都和大阪 (美国商业资讯) — 2016年早些时候，京都大学创新中心和松下公司的研究人员开发了一款基于雷达的设备，它能够即时、准确测量机体的生命体征，而现在他们已对该款设备进行了改良。 本新闻稿包含多媒体。此处查看新闻稿全文： http://www.businesswire.com/news/home/20171009006131/zh-CN/...
View ArticleClik here to view.
Seattle Genetics and Astellas Initiate Pivotal Trial of Enfortumab Vedotin...
BOTHELL, Wash. & TOKYO Seattle Genetics, Inc. (NASDAQ: SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) today announced dosing of the first patient...
View ArticleClik here to view.
Orthocell Appoints Surgical Specialties as Exclusive Distributor
PERTH, Australia Regenerative medicine company Orthocell Limited (ASX:OCC, “Orthocell” or the “Company”) is pleased to announce it has appointed Surgical Specialties Pty Ltd (Surgical Specialties)...
View ArticleClik here to view.
Avita Medical A$16.9 Million Capital Raising
VALENCIA, Calif. & PERTH, Australia & LONDON Avita Medical (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company specialising in the treatment of wounds and skin defects, is undertaking...
View ArticleClik here to view.
Innovus Pharmaceuticals Expands Its International Proprietary Product Patent...
SAN DIEGO Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB Venture Market: INNV), an emerging over-the-counter (“OTC”) consumer goods and specialty pharmaceutical company...
View ArticleClik here to view.
Cogstate Announces First U.S. Deployment of the Cognigram™ System at the...
BOSTON The cognitive science company, Cogstate today announced the commercial deployment of its Cognigram™ digital cognitive assessment system at the University of Notre Dame. This placement...
View ArticleClik here to view.
Düber Technologies Inc.宣布推出基于SAFT的ICO以变革大麻行业
西雅图 (美国商业资讯)–为大麻行业服务的软件即服务(SaaS)提供商düber Technologies Inc.今天宣布了该公司的首次代币发行(ICO)。预售将于UTC时间10月11日15时01分开始。本次ICO按照未来代币简单协议(SAFT)发行，并根据美国证券法第4(a)2章第D节第506(c)款规则及其修正案（“美国证券法”）的规定，将代币购买者认定为投资者。...
View ArticleClik here to view.
Otsuka and Lundbeck Announce Initiation of Two Phase 3 Trials of...
TOKYO & DEERFIELD, Ill. Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Lundbeck announce that patient enrollment has been initiated in two global Phase 3 clinical trials to evaluate brexpiprazole...
View ArticleClik here to view.
和铂医药宣布，已授权信达生物制药使用其全人源单克隆抗体转基因小鼠平台开发多种全人源单克隆抗体新药
中国上海，荷兰鹿特丹和美国马萨诸塞州剑桥 和铂医药（Harbour BioMed）宣布，已授权一家中国优秀的创新型生物制药公司信达生物制药（Innovent Biologics, Inc.）使用其拥有全球专利技术的H2L2转基因小鼠平台，开发多领域的全人源单克隆抗体创新药物。...
View ArticleClik here to view.
Harbour BioMed Announces Multi-Year Transgenic Platform Licensing Agreement...
SHANGHAI & ROTTERDAM, The Netherlands & CAMBRIDGE, Mass. Harbour BioMed announced today that it has licensed its patented H2L2 transgenic mouse platform for generating fully human...
View ArticleClik here to view.
Shionogi Inc. and Purdue Pharma L.P. Announce U.S. Availability of Symproic®...
OSAKA, Japan & FLORHAM PARK, N.J. & STAMFORD, Conn. Shionogi Inc. and Purdue Pharma L.P. announced today that Symproic® (naldemedine) 0.2 mg tablets are now available throughout the United...
View ArticleClik here to view.
Takeda Presents Updated Results from Pivotal Phase 2 ALTA Trial of ALUNBRIGTM...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that data from the pivotal Phase 2 ALTA (ALK in Lung Cancer Trial of AP26113) clinical trial...
View ArticleClik here to view.
Ipsen Announces That Phase 3 CELESTIAL Trial of Cabozantinib Meets Primary...
PARIS Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) and its partner Exelixis (NASDAQ: EXEL) today announced that its global phase 3 CELESTIAL trial met its primary endpoint of overall survival...
View ArticleClik here to view.
Novocure Announces Data Presentations at the IASLC 18th World Conference on...
ST. HELIER, Jersey Novocure (NASDAQ: NVCR) announced today five data presentations at the International Associations for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer,...
View ArticleClik here to view.
Covance Recognized with Frost & Sullivan Asia Pacific CRO Customer Value...
BURLINGTON, N.C. LabCorp (NYSE: LH), a leading global life sciences company, announced today that its Covance Drug Development business (Covance) has been awarded the 2017 Frost & Sullivan Asia...
View ArticleClik here to view.
Dr. Reddy’s to Release Q2 FY18 Results on October 31, 2017
HYDERABAD, India Dr. Reddy’s Laboratories (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) will announce results for the Second Quarter ended September 30, 2017 on Tuesday, October 31, 2017 after the Board...
View ArticleClik here to view.
Anika Announces Regulatory Approval for MONOVISC® in Australia for the...
BEDFORD, Mass. Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology,...
View ArticleClik here to view.
Acerus Announces Licensing of NATESTO® in South East Asian Countries
TORONTO Acerus Pharmaceuticals Corporation (TSX:ASP) today announced the signing of an agreement granting Eu Hwa Pte LTD. (“EU”) the exclusive right to market NATESTO® in Thailand, Malaysia/Brunei,...
View ArticleClik here to view.
Takeda and HemoShear Therapeutics Enter into Exclusive Drug Discovery...
OSAKA, Japan & CHARLOTTESVILLE, Va. Takeda Pharmaceutical Company Limited (TSE: 4502) and HemoShear Therapeutics, LLC, a privately held biotechnology company, today announced a partnership to...
View ArticleClik here to view.
武田呈报ALUNBRIGTM (brigatinib)治疗ALK阳性非小细胞肺癌枢纽性2期ALTA试验的更新结果
马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社(TSE: 4502)今天宣布，枢纽性2期ALTA (ALK in Lung Cancer Trial of AP26113)临床试验数据将于日本标准时间10月16日星期一下午4:30 – 4:40在国际肺癌研究学会(IASLC)第18届世界肺癌大会(WCLC)上进行口述呈报，该试验评估ALUNBRIGTM...
View Article